Similarly, in hepatocytes, cGAS-STING signaling drives inflammation, lipid accumulation, and fibrosis, contributing to the progression of NAFLD and NASH. This evidence concerns the gene STING1 and metabolic dysfunction-associated steatotic liver disease.